Income Statement
OUTLOOK THERAPEUTICS, INC.
OTLK
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Sep 30, 2025 2025 FY | Sep 30, 2024 2024 FY | Sep 30, 2023 2023 FY | Sep 30, 2022 2022 FY | Sep 30, 2021 2021 FY | Sep 30, 2020 2020 FY | Sep 30, 2019 2019 FY | Sep 30, 2018 2018 FY | Sep 30, 2017 2017 FY | Sep 30, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
1.41 | - | - | - | - | - | 8.15 | 3.09 | 3.81 | 2.98 |
|
Cost of Revenue
|
1.36 | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
0.06 | - | - | - | - | - | 8.15 | 3.09 | 3.81 | 2.98 |
|
Operating Expenses
|
67.12 | -71.70 | 53.13 | -63.07 | 51.73 | 36.84 | 44.45 | 32.73 | 39.69 | 54.74 |
|
Research & Development
|
27.18 | 41.76 | 26.45 | 42.33 | 38.96 | 26.34 | 23.81 | 18.50 | 23.81 | 33.10 |
|
Selling, General & Administrative
|
39.94 | 29.94 | 26.67 | 20.74 | 12.77 | 9.97 | 9.37 | 14.23 | 15.88 | 21.64 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-67.06 | -71.70 | -53.13 | -63.07 | -51.73 | -36.84 | -36.30 | -29.64 | -35.88 | -51.76 |
|
Non-Operating Income
|
-3.08 | 3.66 | 5.85 | 2.98 | 1.43 | 1.67 | 1.64 | 4.10 | 2.47 | 1.47 |
|
Interest Income
|
0.09 | 0.91 | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | 2.07 | 1.66 | 0.89 | 1.76 | 3.47 | 3.89 | 5.63 | 1.47 |
|
Other Non-Op Income / Expense
|
-0.14 | -0.10 | -0.01 | -0.05 | -0.05 | - | - | - | - | - |
|
Income Before Tax
|
-63.98 | -75.36 | -58.98 | -66.05 | -53.16 | -38.51 | -37.93 | -33.74 | -38.35 | -53.23 |
|
Income Tax Expense
|
-1.55 | 0.00 | 0.00 | 0.00 | 0.00 | -3.27 | -3.41 | -3.65 | 0.50 | 0.10 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-62.42 | -75.37 | -58.98 | -66.05 | -53.16 | -35.24 | -34.52 | -30.09 | -38.85 | -53.33 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Sep 30, 2025 2025 FY | Sep 30, 2024 2024 FY | Sep 30, 2023 2023 FY | Sep 30, 2022 2022 FY | Sep 30, 2021 2021 FY | Sep 30, 2020 2020 FY | Sep 30, 2019 2019 FY | Sep 30, 2018 2018 FY | Sep 30, 2017 2017 FY | Sep 30, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-66.94 | -71.59 | -53.08 | -62.87 | -51.46 | -36.29 | -32.94 | -26.59 | -33.19 | -49.36 |
|
Earnings Per Share (Basic)
|
-1.79 | -4.06 | -0.24 | -0.31 | -0.35 | - | - | -1.22 | -1.67 | - |
|
Diluted EPS
|
-1.79 | -4.06 | -0.24 | -0.31 | -0.35 | - | - | -1.22 | -1.80 | - |
|
Weighted Average Shares
|
34.80 | 18.55 | 250.18 | 212.08 | 152.68 | - | - | 39.46 | 24.02 | - |
|
Diluted Weighted Avg Shares
|
34.80 | 18.55 | 250.18 | 212.08 | 152.68 | - | - | 39.46 | 24.04 | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - |